[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bionxt Solutions Inc (BNXTF)

Bionxt Solutions Inc (BNXTF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 44,683
  • Shares Outstanding, K 122,486
  • Annual Sales, $ 20 K
  • Annual Income, $ -3,880 K
  • EBIT $ -3 M
  • EBITDA $ -3 M
  • 60-Month Beta 0.87
  • Price/Sales 4,468.30
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings $-0.01 on 11/28/25
  • Next Earnings Date 06/25/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2602 +30.25%
on 04/15/26
0.3936 -13.90%
on 04/02/26
-0.0734 (-17.80%)
since 03/27/26
3-Month
0.2602 +30.25%
on 04/15/26
0.5060 -33.02%
on 02/18/26
-0.1526 (-31.05%)
since 01/28/26
52-Week
0.2602 +30.25%
on 04/15/26
0.8000 -57.64%
on 08/20/25
+0.0775 (+29.65%)
since 04/29/25

Most Recent Stories

More News
BioNxt Reports “Intention to Grant” Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies

VANCOUVER, BC / November 4, 2025 / BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce that its wholly owned German subsidiary, Vektor Pharma...

BNXT.CN : 0.4600 (-1.08%)
BNXTF : 0.3389 (-7.10%)
BioNxt Reports “Readiness to Grant” Patent Notification from the Eurasian Patent Organization

VANCOUVER, BC / October 30, 2025 / BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is...

BNXT.CN : 0.4600 (-1.08%)
BNXTF : 0.3389 (-7.10%)
BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug

NEW YORK , Oct. 23, 2025 /PRNewswire/ -- BioNxt Solutions Inc. (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience company developing next-generation drug delivery technologies, has launched a 15-day...

BNXTF : 0.3389 (-7.10%)
BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug

BioNxt Solutions Inc. (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience company developing next-generation drug delivery technologies, has launched a 15-day dosing optimization study for its lead product...

BNXT.CN : 0.4600 (-1.08%)
BNXTF : 0.3389 (-7.10%)
BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study

VANCOUVER, BC / October 21, 2025 / BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in next-generation drug delivery technologies,...

BNXT.CN : 0.4600 (-1.08%)
BNXTF : 0.3389 (-7.10%)
BioNxt Secures Fast-Track Patent Filing for MS Treatment

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. BioNxt Solutions...

BNXTF : 0.3389 (-7.10%)
BioNxt Solutions Completes Debt Settlement to Strengthen Financial Position

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement...

BNXTF : 0.3389 (-7.10%)
BioNxt Solutions Strengthens Market Position with Strategic Advisor and Investor Relations Team

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. BioNxt Solutions...

BNXTF : 0.3389 (-7.10%)
BioNxt Advances Targeted Chemotherapy Delivery Platform

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. BioNxt Solutions...

BNXTF : 0.3389 (-7.10%)
BioNxt Advances Semaglutide Oral Film with Successful Trials

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

BNXTF : 0.3389 (-7.10%)

Business Summary

BioNxt Solutions Inc. is a bioscience accelerator focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations. BioNxt Solutions Inc., formerly known...

See More

Key Turning Points

3rd Resistance Point 0.3988
2nd Resistance Point 0.3894
1st Resistance Point 0.3771
Last Price 0.3389
1st Support Level 0.3554
2nd Support Level 0.3460
3rd Support Level 0.3337

See More

52-Week High 0.8000
Fibonacci 61.8% 0.5938
Fibonacci 50% 0.5301
Fibonacci 38.2% 0.4664
Last Price 0.3389
52-Week Low 0.2602

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.